Taramarie Piecyk
Psychiatric/Mental Health · Cranston, RINPI 1548550171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations.
Across 116 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$310
- Otsuka America Pharmaceutical, Inc.$286
- Amgen$212
- Vanda Pharmaceuticals Inc.$212
- Alkermes, Inc.$192
- Teva Pharmaceuticals USA, Inc.$140
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,580100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $310 |
| Otsuka America Pharmaceutical, Inc. | 15 | $286 |
| Amgen | 6 | $212 |
| Vanda Pharmaceuticals Inc. | 8 | $212 |
| Alkermes, Inc. | 8 | $192 |
| Teva Pharmaceuticals USA, Inc. | 7 | $140 |
| Lundbeck LLC | 6 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $101 |
| Bayer | 5 | $99 |
| AstraZeneca(2 entities) | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Boehringer Ingelheim | 3 | $77 |
| Corium, LLC | 4 | $74 |
| Mannkind Corporation | 3 | $72 |
| Sunovion Pharmaceuticals Inc. | 3 | $67 |
| Johnson & Johnson | 2 | $62 |
| Lilly USA, LLC | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Abbott | 2 | $44 |
| Medtronic | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Merck | 2 | $33 |
| Ironshore Pharmaceuticals Inc. | 1 | $26 |
| Mylan Specialty L.p. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$122
How this compares
$2,580 in reported general payments places this provider in the 80th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 12 | $129 |
| Sertraline Hcl | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cranston
- Eniayo EgberongbeCranston$12K
- Anita ObengCranston$8K
- Cristiana RitwikCranston$4K
- Barbara ForloneyCranston$3K
- Tanille LouisCranston$2K
- Samantha Shawn MarshBradford$639K
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Deborah HorvitzWarwick$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.